Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.

 

Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
   
Paper Publishing WeChat
Book Publishing WeChat
(or Email:book@scirp.org)

Article citations

More>>

M. Peeters, et al., “Randomized Phase III Study of Panitumumab (pmab) with FOLFIRI versus FOLFIRI Alone as Second-Line Treatment (tx) in Patients (pts) with Metastatic Colorectal Cancer (mCRC): Patient-Reported Outcomes (PRO),” Gastrointestinal Cancers Symposium, Orland, 22-24 January 2010.

has been cited by the following article: